Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 5/2024

18.12.2023 | Review Article

The percentage of controlled chronic rhinosinusitis after treatment: a systematic review and meta-analysis

verfasst von: Tianhao Huang, Jiahui Zhou, Fan Yuan, Yan Yan, Dawei Wu

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Chronic rhinosinusitis (CRS) is a chronic disease with a high recurrence rate, and the aim of treating CRS is to maintain disease control. Recently, a series of CRS control instruments have been developed to assess the control levels. We pooled existing studies to evaluate the percentage of controlled CRS after treatment in patients with CRS.

Methods

A systematic literature review and meta-analysis using PubMed, Google Scholar, Scopus, and Cochrane databases was conducted to identify studies assessing CRS control. Both comprehensive assessments and self-report of CRS control were included.

Results

9 studies with 1931 patients after treatment and 295 patients before treatment were included. CRS control assessments of the 2012 European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS 2012), EPOS 2020, and Sinus Control Test (SCT) were comprehensive assessments utilized in the clinic practice. The self-report assessment included patient-reported global level of CRS control. These existing disease control instruments categorized patients into three (uncontrolled, partly controlled, and controlled) or five (not at all, a little, somewhat, very, and completely) control categories. Only 8% (95% CI 0.05–0.11) of patients with CRS stayed well controlled before treatment assessed by comprehensive assessments. About 35% (95% CI 0.22–0.49) of patients achieved well controlled after treatment when assessed by the comprehensive measures. Meanwhile, 40% (95% CI 0.28–0.52) of patients reported well controlled after treatment when using self-report.

Conclusion

About 35–40% of patients with CRS showed well controlled after treatment, which stressed the importance of identifying these undertreated patients with CRS.
Literatur
1.
Zurück zum Zitat Hastan D, Fokkens WJ, Bachert C et al (2011) Chronic rhinosinusitis in Europe: an underestimated disease. A GA (2) LEN study. Allergy 66(9):1216–1223CrossRefPubMed Hastan D, Fokkens WJ, Bachert C et al (2011) Chronic rhinosinusitis in Europe: an underestimated disease. A GA (2) LEN study. Allergy 66(9):1216–1223CrossRefPubMed
2.
Zurück zum Zitat Palmer JN, Messina JC, Biletch R, Grosel K, Mahmoud RA (2019) A cross-sectional, population- based survey of US adults with symptoms of chronic rhinosinusitis. Allergy Asthma Proc 40:4182CrossRef Palmer JN, Messina JC, Biletch R, Grosel K, Mahmoud RA (2019) A cross-sectional, population- based survey of US adults with symptoms of chronic rhinosinusitis. Allergy Asthma Proc 40:4182CrossRef
3.
Zurück zum Zitat Hirsch AG, Stewart WF, Sundaresan AS et al (2017) Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample. Allergy 72(2):274–281CrossRefPubMed Hirsch AG, Stewart WF, Sundaresan AS et al (2017) Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample. Allergy 72(2):274–281CrossRefPubMed
4.
Zurück zum Zitat DeConde AS, Soler ZM (2016) Chronic rhinosinusitis: epidemiology and burden of disease. Am J Rhinol Allergy 30(2):134–139CrossRefPubMed DeConde AS, Soler ZM (2016) Chronic rhinosinusitis: epidemiology and burden of disease. Am J Rhinol Allergy 30(2):134–139CrossRefPubMed
5.
Zurück zum Zitat Baguley C, Brownlow A, Yeung K, Pratt E, Sacks R, Harvey R (2014) The fate of chronic rhinosinusitis sufferers after maximal medical therapy: the fate of CRS sufferers after MMT. Int Forum Allergy Rhinol 4(7):525–532CrossRefPubMed Baguley C, Brownlow A, Yeung K, Pratt E, Sacks R, Harvey R (2014) The fate of chronic rhinosinusitis sufferers after maximal medical therapy: the fate of CRS sufferers after MMT. Int Forum Allergy Rhinol 4(7):525–532CrossRefPubMed
6.
Zurück zum Zitat Alanin MC, Hopkins C (2020) Effect of functional endoscopic sinus surgery on outcomes in chronic rhinosinusitis. Curr Allergy Asthma Rep 20(7):27CrossRefPubMed Alanin MC, Hopkins C (2020) Effect of functional endoscopic sinus surgery on outcomes in chronic rhinosinusitis. Curr Allergy Asthma Rep 20(7):27CrossRefPubMed
8.
Zurück zum Zitat DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL (2017) Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis: polyp recurrence after ESS. Laryngoscope 127(3):550–555CrossRefPubMed DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL (2017) Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis: polyp recurrence after ESS. Laryngoscope 127(3):550–555CrossRefPubMed
9.
10.
Zurück zum Zitat Wu D, Bleier B, Wei Y (2020) Definition and characteristics of acute exacerbation in adult patients with chronic rhinosinusitis: a systematic review. J Otolaryngol Head Neck Surg 49(1):62CrossRefPubMedPubMedCentral Wu D, Bleier B, Wei Y (2020) Definition and characteristics of acute exacerbation in adult patients with chronic rhinosinusitis: a systematic review. J Otolaryngol Head Neck Surg 49(1):62CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Banglawala SM, Schlosser RJ, Morella K et al (2016) Qualitative development of the sinus control test: a survey evaluating sinus symptom control. Int Forum Allergy Rhinol 6(5):491–499CrossRefPubMed Banglawala SM, Schlosser RJ, Morella K et al (2016) Qualitative development of the sinus control test: a survey evaluating sinus symptom control. Int Forum Allergy Rhinol 6(5):491–499CrossRefPubMed
12.
Zurück zum Zitat Little RE, Schlosser RJ, Smith TL et al (2021) Disease control after surgery for chronic rhinosinusitis: prospective, multi-institutional validation of the Sinus Control Test. Int Forum Allergy Rhinol 11(2):106–114CrossRefPubMed Little RE, Schlosser RJ, Smith TL et al (2021) Disease control after surgery for chronic rhinosinusitis: prospective, multi-institutional validation of the Sinus Control Test. Int Forum Allergy Rhinol 11(2):106–114CrossRefPubMed
13.
Zurück zum Zitat Lourijsen ES, Reitsma S, Vleming M et al (2022) Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial. Lancet Respir Med 10(4):337–346CrossRefPubMed Lourijsen ES, Reitsma S, Vleming M et al (2022) Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial. Lancet Respir Med 10(4):337–346CrossRefPubMed
14.
Zurück zum Zitat van der Veen J, Seys SF, Timmermans M, Levie P et al (2017) Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre. Allergy 72(2):282–290CrossRefPubMed van der Veen J, Seys SF, Timmermans M, Levie P et al (2017) Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre. Allergy 72(2):282–290CrossRefPubMed
15.
Zurück zum Zitat Wang KH, Deng J, Yang M et al (2021) Concordant systemic and local eosinophilia relates to poorer disease control in patients with nasal polyps. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 56(10):1042–1050PubMed Wang KH, Deng J, Yang M et al (2021) Concordant systemic and local eosinophilia relates to poorer disease control in patients with nasal polyps. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 56(10):1042–1050PubMed
16.
Zurück zum Zitat Kohli P, Soler ZM, Storck KA, Shahangian A, Banglawala SM, Schlosser RJ (2017) Responsiveness and reliability of the Sinus Control Test in chronic rhinosinusitis. Rhinology 55(1):39–44CrossRefPubMed Kohli P, Soler ZM, Storck KA, Shahangian A, Banglawala SM, Schlosser RJ (2017) Responsiveness and reliability of the Sinus Control Test in chronic rhinosinusitis. Rhinology 55(1):39–44CrossRefPubMed
17.
Zurück zum Zitat Tao X, Chen F, Sun Y et al (2018) Prediction models for postoperative uncontrolled chronic rhinosinusitis in daily practice. Laryngoscope 128(12):2673–2680CrossRefPubMed Tao X, Chen F, Sun Y et al (2018) Prediction models for postoperative uncontrolled chronic rhinosinusitis in daily practice. Laryngoscope 128(12):2673–2680CrossRefPubMed
18.
Zurück zum Zitat Campbell AP, Hoehle LP, Phillips KM, Caradonna DS, Gray ST, Sedaghat AR (2018) Symptom control in chronic rhinosinusitis is an independent predictor of productivity loss. Eur Ann Otorhinolaryngol Head Neck Dis 135(4):237–241CrossRefPubMed Campbell AP, Hoehle LP, Phillips KM, Caradonna DS, Gray ST, Sedaghat AR (2018) Symptom control in chronic rhinosinusitis is an independent predictor of productivity loss. Eur Ann Otorhinolaryngol Head Neck Dis 135(4):237–241CrossRefPubMed
19.
Zurück zum Zitat McCann AC, Trope M, Walker VL et al (2021) Olfactory dysfunction is not a determinant of patient-reported chronic rhinosinusitis disease control. Laryngoscope 131(7):E2116–E2120CrossRefPubMed McCann AC, Trope M, Walker VL et al (2021) Olfactory dysfunction is not a determinant of patient-reported chronic rhinosinusitis disease control. Laryngoscope 131(7):E2116–E2120CrossRefPubMed
20.
Zurück zum Zitat Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRefPubMed Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRefPubMed
21.
Zurück zum Zitat Rostom A, Dubé C, Cranney A et al (2004) Celiac disease. Agency for Healthcare, Rockville (Evidence Reports/Technology Assessments, No. 104.) Appendix D. Quality Assessment Forms) Rostom A, Dubé C, Cranney A et al (2004) Celiac disease. Agency for Healthcare, Rockville (Evidence Reports/Technology Assessments, No. 104.) Appendix D. Quality Assessment Forms)
22.
Zurück zum Zitat Hu J, Dong Y, Chen X et al (2015) Prevalence of suicide attempts among Chinese adolescents: a meta-analysis of cross-sectional studies. Compr Psychiatry 61:78–89CrossRefPubMed Hu J, Dong Y, Chen X et al (2015) Prevalence of suicide attempts among Chinese adolescents: a meta-analysis of cross-sectional studies. Compr Psychiatry 61:78–89CrossRefPubMed
23.
Zurück zum Zitat Higgins JP, Altman DG, Gøtzsche PC et al (2011) Cochrane bias methods group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:5928CrossRef Higgins JP, Altman DG, Gøtzsche PC et al (2011) Cochrane bias methods group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:5928CrossRef
24.
Zurück zum Zitat Fokkens WJ, Lund VJ, Mullol J (2012) EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 50(1):1–12CrossRefPubMed Fokkens WJ, Lund VJ, Mullol J (2012) EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 50(1):1–12CrossRefPubMed
25.
Zurück zum Zitat Sedaghat AR, Phillips KM (2023) Defining ‘control’ of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 31(1):17–23CrossRefPubMed Sedaghat AR, Phillips KM (2023) Defining ‘control’ of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 31(1):17–23CrossRefPubMed
26.
Zurück zum Zitat Fokkens WJ, Lund VJ, Hopkins C (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58:1–464CrossRefPubMed Fokkens WJ, Lund VJ, Hopkins C (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58:1–464CrossRefPubMed
27.
Zurück zum Zitat Phillips KM, Singerman KW, Sedaghat AR (2022) Individual symptom visual analogue scale severity scores for determining EPOS guideline-based chronic rhinosinusitis disease control. Rhinology 60–3:229–235 Phillips KM, Singerman KW, Sedaghat AR (2022) Individual symptom visual analogue scale severity scores for determining EPOS guideline-based chronic rhinosinusitis disease control. Rhinology 60–3:229–235
28.
Zurück zum Zitat Snidvongs K, Heller GZ, Sacks R, Harvey RJ (2014) Validity of European position paper on rhinosinusitis disease control assessment and modifications in chronic rhinosinusitis. Otolaryngol Neck Surg 150(3):479–486CrossRef Snidvongs K, Heller GZ, Sacks R, Harvey RJ (2014) Validity of European position paper on rhinosinusitis disease control assessment and modifications in chronic rhinosinusitis. Otolaryngol Neck Surg 150(3):479–486CrossRef
29.
Zurück zum Zitat Sedaghat AR, Hoehle LP, Gray ST (2018) Chronic rhinosinusitis control from the patient and physician perspectives: Understanding CRS disease control. Laryngoscope Investig Otolaryngol 3(6):419–433CrossRefPubMedPubMedCentral Sedaghat AR, Hoehle LP, Gray ST (2018) Chronic rhinosinusitis control from the patient and physician perspectives: Understanding CRS disease control. Laryngoscope Investig Otolaryngol 3(6):419–433CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Gray ST, Phillips KM, Hoehle LP, Caradonna DS, Sedaghat AR (2017) The 22-item Sino-Nasal Outcome Test accurately reflects patient-reported control of chronic rhinosinusitis symptomatology: SNOT-22 and CRS symptom control. Int Forum Allergy Rhinol 7(10):945–951CrossRefPubMed Gray ST, Phillips KM, Hoehle LP, Caradonna DS, Sedaghat AR (2017) The 22-item Sino-Nasal Outcome Test accurately reflects patient-reported control of chronic rhinosinusitis symptomatology: SNOT-22 and CRS symptom control. Int Forum Allergy Rhinol 7(10):945–951CrossRefPubMed
31.
Zurück zum Zitat Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, Toppila-Salmi S, Bernal-Sprekelsen M, Mullol J (2020) Executive summary of EPOS 2020 including integrated care pathways. Rhinology 58(2):82–111CrossRefPubMed Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, Toppila-Salmi S, Bernal-Sprekelsen M, Mullol J (2020) Executive summary of EPOS 2020 including integrated care pathways. Rhinology 58(2):82–111CrossRefPubMed
32.
Zurück zum Zitat Guo CL, Liao B, Liu JX, Pan L, Liu Z (2021) Predicting difficult-to-treat chronic rhinosinusitis by noninvasive biological markers. Rhinology 59(1):81–90PubMed Guo CL, Liao B, Liu JX, Pan L, Liu Z (2021) Predicting difficult-to-treat chronic rhinosinusitis by noninvasive biological markers. Rhinology 59(1):81–90PubMed
33.
Zurück zum Zitat Sedaghat AR, Singerman KW, Phillips KM (2022) Discordance of chronic rhinosinusitis disease control between EPOS guidelines and patient perspectives identifies utility of patient-rated control assessment. Rhinology 60(6):444–452PubMed Sedaghat AR, Singerman KW, Phillips KM (2022) Discordance of chronic rhinosinusitis disease control between EPOS guidelines and patient perspectives identifies utility of patient-rated control assessment. Rhinology 60(6):444–452PubMed
Metadaten
Titel
The percentage of controlled chronic rhinosinusitis after treatment: a systematic review and meta-analysis
verfasst von
Tianhao Huang
Jiahui Zhou
Fan Yuan
Yan Yan
Dawei Wu
Publikationsdatum
18.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 5/2024
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-023-08363-5

Weitere Artikel der Ausgabe 5/2024

European Archives of Oto-Rhino-Laryngology 5/2024 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.